Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver.
Explore this paper's citation graph
Summary
It is concluded that liver transplantation should be considered for patients with decompensated HBsAg-positive hepatitis B surface antigen-positive liver cirrhosis and antiviral therapy for Patients with HBeAg- positive compensated cirrhotic disease.
- Type
- article
- Published
- 1992-11-01
- Cited by
- 427
- References
- 39
- Access
- Open access
- OpenAlex
- https://openalex.org/W1960579853
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:40010622
Keywords
Medicine, Gastroenterology, Cirrhosis, Internal medicine, HBsAg
References
- Letter: S.S.P.E. and Salk vaccine.
- Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens.
- Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection.
- Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B.
- Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis.
- The development of cirrhosis in patients with chronic type B hepatitis: A prospective study
- A method to evaluate changes in prognostic status during follow-up, illustrated by an assessment of the effect of a rebleed in patients with oesophageal variceal bleeding.
- Changes of laboratory variables with time in cirrhosis: Prognostic and therapeutic significance
- Natural history and prognostic factors for chronic hepatitis type B.
- NATURAL HISTORY OF LIVER DISEASE IN CHRONIC HEPATITIS B SURFACE ANTIGEN CARRIERS: Survey of 100 Patients from Great Britain
- Follow-up study of 582 liver cirrhosis patients for 26 years in Japan.
- A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection
- Natural history of hepatitis-associated antigen-positive chronic liver disease.
- Long-term follow-up of chronic active hepatitis of moderate severity.
- Prognostic Value of Child‐Turcotte Criteria in Medically Treated Cirrhosis
- Letter: Dangers of petrol used as solvent.
- Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti‐HBe in chronic hepatitis type B
- The natural course of hepatitis B surface antigen-positive chronic active hepatitis in Taiwan.
- Survival in chronic hepatitis B. An analysis of 379 patients.
- Chronic type B hepatitis and the “healthy” Hbsag carrier state
Cited by
- Cost-effectiveness of Interferon-2b Treatment for Hepatitis B e Antigen-Positive Chronic Hepatitis B
- Therapy for chronic hepatitis B infection.
- Hepatitis B and end-stage liver disease.
- Comparison of the Efficacies and Safety of Combined Therapy between Telbivudine Plus Adefovir and Lamivudine Plus Adefovir in Patients with Hepatitis B Virus Infection in Real-World Practice
- Albumin–Bilirubin Score Differentiates Liver Fibrosis Stage and Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Virus Infection: A Retrospective Cohort Study
- Treatment of chronic hepatitis B with interferon-alpha: cost-effectiveness in developing countries.
- Hepatitis B in the Human Immunodeficiency Virus-Infected Patient: Epidemiology, Natural History, and Treatment
- Clinical Significance of Serum Prealbumin Concentration in Patients with Liver Cirrhosis
- Management of Chronic Hepatitis B
- Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma.
- The role of the innate immune system in chronic hepatitis B infection
- The use of Chinese herbal medicines associated with reduced mortality in chronic hepatitis B patients receiving lamivudine treatment.
- Doxorubicin Activates Hepatitis B Virus Replication by Elevation of p21 (Waf1/Cip1) and C/EBPα Expression
- Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe-positive chronic hepatitis B: results of an open, controlled trial.
- The cost‐effectiveness and budget impact of competing therapies in hepatic encephalopathy – a decision analysis
- Prognosis of hepatitis B‐related liver cirrhosis in the era of oral nucleos(t)ide analog antiviral agents
- Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
- Cost‐effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria
- Antiviral agents for hepatitis B virus‐related cirrhosis
- Natural history of chronic hepatitis B and C
Related papers
- [Spontaneous bacterial peritonitis in the patients with liver cirrhosis].
- Spontaneous bacterial peritonitis in cardiac ascites: A case report
- Frequency of Spontaneous Bacterial Peritonitis in Patients of Liver Cirrhosis with Ascites at Tanta University Hospitals
- Clinical analysis of spontaneous bacterial peritonitis in cirrhotic patients with ascites
- Frequency of spontaneous bacterial peritonitis in 265 cirrhotics with ascites
- Clinical significance of serum and ascites procalcitonin levels in liver cirrhotic patients with spontaneous bacterial peritonitis
- DIAGNOSTIC AND PREDICTIVE POTENTIAL OF THE C-REACTIVE PROTEIN IN SERUM AND ASCITES FOR SPONTANEOUS BACTERIAL PERITONITIS IN PATIENTS WITH LIVER CIRRHOSIS AND ASCITES
- Spontaneous bacterial peritonitis: risk factors and relationship to serum-ascites albumin gradient in chronic liver disease patient